Regorafenib EP Impurity E | CAS 2098799-13-2   - Solicitar cotización

Regorafenib EP Impurity E is chemically 94-Chloro-34-[[[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino]-53-fluoro-N-methyl-7-oxo-93-(trifluoromethyl)-2,4-dioxa-6,8-diaza-1(4)-pyridina-3(1,3),5(1,4),9(1)-tribenzenanonaphane-12-carboxamide.(as per EP) ; 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}-3-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}-3-fluorophenoxy)phenoxy)-N-methylpicolinamide.(as per USP). It is also known as 4-Arylurea Regorafenib Analog (USP). Regorafenib EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline. Regorafenib EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Regorafenib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.